MODEL-BASED MINIMUM ANTICIPATED BIOLOGICAL EFFECT LEVEL (MABEL) APPROACH LED TO SAFE HUMAN STARTING DOSE OF THREE DOMAIN ANTIBODIES FOR AUTOIMMUNE DISEASES.
CLINICAL PHARMACOLOGY & THERAPEUTICS(2015)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined